Trigger Finger: Comparative Study between Corticosteroid Injection and Percutaneous Release
V Singh, S Chong, S Marriapan
V Singh, S Chong, S Marriapan. Trigger Finger: Comparative Study between Corticosteroid Injection and Percutaneous Release. The Internet Journal of Orthopedic Surgery. 2005 Volume 3 Number 2.
Aim: To determine effectiveness of corticosteroid injection and percutaneous release; in terms of symptomatic relieve, patient satisfaction and complications.
Trigger finger is a common problem encountered in orthopaedic clinics. It is characterised by inability to flex or extend the digit smoothly. It is also known as stenosing tenosynovitis. All the digits can be involved but the ring, thumb, long, index and small fingers are the most commonly involved, in that order of frequency 1 2 .
Primary trigger finger is usually idiopathic and occurs more frequently in middle-aged women, but can be seen even in infancy. Secondary trigger finger of the digits can occur in patients with rheumatoid arthritis, diabetes mellitus, gout and other disease entities that cause connective tissue disorder.
Pathogenesis of trigger finger is due to pathological disproportion between the volume of the retinacular sheath and its contents. This disproportion inhibits gliding of the tendon through A1 pulley. Two types of pathological involvement are seen, nodular and diffuse types 3 . These finding is based on palpation of swelling of the tendon sheath. Nodular type is commonly seen in idiopathic trigger fingers and diffuse type is seen in conjunction with connective tissue diseases. Trigger fingers are graded according to severity. Commonly used classification is by Quinnell 4 (figure 1).
Various method of treatment has been advocated ranging from conservative treatment (consisting of massage, ice, NSAIDS and splinting), corticosteroid injection, percutaneous release and open release. Surgical release is recommended if non-operative treatment fails. It is postulated that 85% of trigger fingers respond well to conservative treatment. The success of the treatment is dependant on duration of complaint, severity of triggering and type of triggering 5 .
Materials and Method
This is prospective randomized study, conducted in Orthopaedic Department at Penang General Hospital from 1 st January 2005 till 30 th June 2005. We compared the effectiveness of corticosteroid injection and percutaneous release, in terms of symptomatic relieve, patient satisfaction and complications.
Patients who presented with Grade 2 and Grade 3 trigger finger were randomized into 2 groups. Randomization was done by adding together the birth year of the patient and dividing it by 2. Those with even numbers were allocated to the corticosteroid group and odd numbers to the percutaneous group. All the patients were explained the nature of the study and a written consent was taken. Thumbs were excluded from the study because in our center, they are usually treated by open release. This is due to the proximity of radial digital nerve to the A1 pulley making it susceptible to damage in a percutaneous release. These patients were followed up weekly for a month and 3 monthly for a year.
A 3 cm 3 syringe is used to infiltrate 1% lignocaine around the A1 pulley area. Patient is asked to actively wiggle the affected digit to ascertain the position of the thickened A1 pulley. A 20-gauge needle is then inserted with the sharp bevel parallel to the tendon. The needle is inserted one third the distance from the distal palmar crease to the base of the middle, ring, or small finger. In the case of the index finger, the needle is inserted one third the distance from the distal thenar crease and the base of the finger. These positions correlate with the middle of the A1 pulley. The needle is then stroked longitudally proximally and distally to transect the pulley 6 .
The distal palm in the area of the A1 pulley is cleansed with povidone iodine solution. A 30-gauge 0.5-inch needle is used to anesthetize the area around the A1 pulley as well as the tendon sheath with 1 mL of 1% lignocaine without epinephrine. Then 1 mL of the triamcinolone is mixed with 1 mL of 1% lignocaine injected into the tendon sheath and around the nodule. The position of the needle is ascertained by asking the patient to wiggle the finger. If the needle is in the tendon proper, there is a paradoxical movement of the needle. A small sterile dressing was applied for a day and patient was allowed to return to normal routine activity. Analgesia is given for 3 days. These patients are advised to return immediately if there were any signs to indicate infection.
These patients were assessed weekly in the clinic for a month, to observe the improvement in the grade of triggering, swelling, pain and patients' satisfaction. Pain was assessed with the visual analog scale.
The statistical analysis was performed with Stats View. Descriptive statistical analysis was used to analyse demographic data. Paired t-test was used to measure the weekly progress in the corticosteroid and percutaneous group respectively, in terms of symptom relieve, patient's satisfaction and complications. Unpaired t-test was used to comparing the effectiveness of treatment between both the groups. A p-value of < 0.01 was considered to be significant.
Twenty-six patients presented to us with trigger fingers. They were randomized to 2 groups, corticosteroid group and percutaneous release group. A total of 12 patients received corticosteroid injections and 14 patients underwent percutaneous release. There were 4 index fingers, 11 middle fingers and 11 ring fingers. The patients presented with symptoms of triggering, pain, palpable nodule, swelling or a combination of these. All of them had the nodular type of trigger finger.
Majority of the patients (45.6%) were 50 to 60 years old with a mean age of 57 years old (figure 2). Occupation wise, 38.5% were manual workers, 30.8% were semi-professionals and 26.9% were housewives. Professionals were rarely involved.
More females (65.4%) were affected with trigger finger compared to males (34.6%). Dominance of the hand had no bearing on the incidence of triggering (Dominant 53.8% and non-dominant 46.2%). In 61.5% of patients, this was the first episode of triggering with 26.9 % and 11.5% presenting with second and third recurrence. Thumb was excluded from this study for reasons noted earlier. Amongst the four fingers, the most commonly involved finger was the middle and ring finger (42.2% each). There was no involvement of the little finger. The most common presenting complaint in our patients was pain with triggering in 42.3%, followed by triggering alone in 23.1% and pain alone in 15.4% of patients.
There was significant improvement in pain in the first two weeks in both the groups. Better improvement in pain was observed in the corticosteroid group of patients as compared to the percutaneous release group, in the first and fourth week.
Triggering was assessed according to the grading described above. There was significant improvement noted in the 1 st week in both the groups. However, there was no statistically significant difference between both the groups. In terms of swelling of the digits, no difference was noted during the course of the treatment in the corticosteroid group. Slight improvement was noted in the percutaneous group after 3 rd week. As for patients' satisfaction, the percutaneous release group reached maximum satisfaction by 2 nd week as appose to the corticosteroid group, which achieve maximum satisfaction one week later.
The corticosteroid group of patients had a complication rate of 10% (1 patient claimed numbness over distal phalanx after corticosteroid injection) and the percutaneous group had 20% complication rate (2 patients developed stiffness of digit which responded to aggressive physiotherapy and 1 patient developed bowstringing of tendon).
There were a total of 4 patients that had recurrence (recurrence rate 15%). Two cases each in both groups. This, occur at 2 to 9 months after the primary procedure. They were treated successfully with open release.
Trigger finger is a common problem encountered in the orthopaedic practice. Eighty five percent responds favourably to conservative treatment such as corticosteroids and nonsteroidal anti-inflammatory. Surgical release (percutaneous or open) is resorted if conservative treatment failed 7 . The decision of mode of treatment depends on grade of the trigger finger and duration of symptoms. Miguel J. Saldana 8 outlined treatment of trigger fingers according to grades of severity as shown in figure 3.
It is generally agreed that grade 0 and grade 1 trigger fingers requires no more than gentle physiotherapy and NSAIDs, failure of which is treatable with corticosteroid injection. Meanwhile grade 4 triggering is usually resistant to conservative treatment and requires surgical release. However, the management of grade 2 and grade 3 trigger finger is a still subject of debate.
First introduced by Howard et al 9 in 1953, the use of steroid injections has been amply reported with varying degrees of success. Many authors have demonstrated good results, as high as 92%, 7-9 in all grades of trigger fingers treated with corticosteroid injections with as many as three injections. This offers us an interesting proposition to treat this mild condition non-surgically and avoid complications of surgical release, which includes digital nerve injury, A2 pulley injury with subsequent bowstringing of the tendons, stiffness and sympathetic dystrophy 10-12 .
Lothoir 10 first reported percutaneous release of a trigger digit, in 1958. He reported good results in 52 digits with no complications with the use of a fine tenotome. This encouraging result paved way for many new techniques and modified instruments to reduce the possible complications associated with percutaneous release.
For example, K.I. Ha 11 described a percutaneous technique using a specially designed knife where 185 patients with grade 3 and 4 triggering were included in this study. Majority (173 patients) achieved satisfactory results. Eleven patients had persistent triggering and one had persistent pain at the release site. No significant complications were noted. Similar result, were also obtained by Shaw-Ruey Lyu 12 . He used a specially designed pulley hook and curved-blade knife.
Regardless the technique used for the percutaneous release, there are some precautions that need to be taken when carrying out such procedures in order to avoid damaging the digital nerves. These are best described by Charles Sorbie 13 , which include; stay in the midline of the digit, extend the finger at the metacarpophalangeal joint, keep the needle perpendicular to the sagital plane and be accurate with the position of the needle tip. He also suggested than percutaneous release could induce painful tenosynovitis with resultant painful finger flexion for several months if corticosteroid is not used with initial local anaesthesia.
Our study supports the use of corticosteroid injection in treating grade 2 and grade 3 trigger fingers. Both the use of corticosteroid and percutaneous release yield almost similar results, but the corticosteroid group is associated with fewer complications. We did not find any difference in the recurrence rate in both methods of treatment.
Mr Vivek Ajit Singh 107-2-5 Desa Acacia. Medan York. 10450 Penang. E mail: email@example.com Tel: 0060124940600